ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO023

Validation of a Cloud-Based Convolutional Neural Network Classifying Arteriovenous Access Aneurysms in a Multicenter Study

Session Information

Category: Augmented Intelligence, Digital Health, and Data Science

  • 300 Augmented Intelligence, Digital Health, and Data Science

Authors

  • Dong, Zijun, Renal Research Institute, New York, New York, United States
  • Zhang, Hanjie, Renal Research Institute, New York, New York, United States
  • Wang, Lin-Chun, Renal Research Institute, New York, New York, United States
  • Ren, Sarah, Renal Research Institute, New York, New York, United States
  • Han, Maggie, Renal Research Institute, New York, New York, United States
  • Tisdale, Lela, Renal Research Institute, New York, New York, United States
  • Gusmao Bittencourt, Valeria, Renal Research Institute, New York, New York, United States
  • Rosales M., Laura, Renal Research Institute, New York, New York, United States
  • Starakiewicz, Piotr, Azura Vascular Care, New York, New York, United States
  • Douglas, Denzil, Azura Vascular Care, New York, New York, United States
  • Shtaynberg, Norbert, Azura Vascular Care, New York, New York, United States
  • Kozyra, Andrzej, Azura Vascular Care, New York, New York, United States
  • Fuca, Nicholas, Azura Vascular Care, New York, New York, United States
  • Prakash-Polet, Sindhuri, Azura Vascular Care, New York, New York, United States
  • Thijssen, Stephan, Renal Research Institute, New York, New York, United States
  • Preddie, Dean C., Azura Vascular Care, New York, New York, United States
  • Kotanko, Peter, Renal Research Institute, New York, New York, United States
Background

Arteriovenous (AV) access aneurysms may become life-threatening, e.g., in the event of ruptures. We developed an artificial intelligence classification application (ACA) that categorizes aneurysms using AV access images. This study prospectively evaluates ACA’s classification of AV aneurysms against physicians specializing in access care.

Methods

The study took place at two vascular access centers in New York, NY, USA. Subjects were assessed by physicians and classified as having “Advanced” or “Not Advanced” AV aneurysms. Six images, two from above the access and two on each side, were taken (Figure. 1c), uploaded to the cloud, and classified by a convolutional neural network within seconds (Figure. 1b). ACA classifications were compared to those made by physicians, and the area under the receiver operating characteristics (AUROC) curves were computed (Figure. 1a). Physicians were blinded to ACA results. Their assessment served as the ground truth.

Results

We included 720 images from 120 subjects (Figure. 1d). Physicians identified a 22% prevalence of advanced aneurysms. ACA classifications resulted in a mean AUROC of 0.907 (95% CI: 0.840-0.952), a median AUROC of 0.893 (95% CI: 0.823-0.942), a minimum AUROC of 0.866 (95% CI: 0.792-0.921), and a maximum AUROC of 0.910 (95% CI: 0.844-0.955) (Figure. 1e).

Conclusion

ACA demonstrated actionable accuracy in classifying AV aneurysms, even with angled images. Our results align with Zhang (CKJ, 2021), where ACA achieved an AUROC of 0.96 (n=402). Importantly, in the 2021 study physicians evaluated only images, whereas in the current study detailed physical exams were performed.
ACA has potential to support aneurysm monitoring, expediting detection and interventions.